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Abstract
 
Infection with 
 
Listeria monocytogenes
 
 causes lymphocyte apoptosis that is mediated by the actions
of the pore-forming virulence factor listeriolysin O (LLO). Previous work showed that activated
lymphocytes were highly sensitive to LLO-induced apoptosis, whereas resting lymphocytes
were less susceptible. We now show that mice deficient in the type I interferon (IFN) receptor
were more resistant to 
 
Listeria
 
 infection and had less apoptotic lesions than wild-type counter-
parts. Furthermore, treatment of resting splenic lymphocytes with recombinant IFN-
 
 
 
A en-
hanced their susceptibility to LLO-induced apoptosis. Together, these data suggest that type I
IFN signaling is detrimental to handling of a bacterial pathogen and may enhance the suscepti-
bility of lymphocytes undergoing apoptosis in response to bacterial pore-forming toxins.
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Introduction
 
Previous studies with 
 
Listeria monocytogenes
 
 have exposed
the role of multiple cytokines at different stages of the in-
fection using gene-ablated mice or neutralizing monoclo-
nal antibodies (for review see references 1 and 2). IL-12,
TNF, and the IL-1 family of proteins participate in activat-
ing different cells and controlling 
 
Listeria
 
 growth. These
early cytokines contribute to the induction of IFN-
 
 
 
, a
product of NK and T cells, and activation of macrophages.
Much is known about the role of type I IFNs (IFN-
 
 
 
and IFN-
 
 
 
) in the antiviral response and type II IFN (IFN-
 
 
 
)
in the antiviral and antibacterial response (3–6). However,
there exists a paucity of data on the role of type I IFNs dur-
ing bacterial infection. Here we report that the absence of
the shared IFN-
 
 
 
/
 
  
 
receptor (IFN-
 
  
 
R
 
 
 
/
 
 
 
) provides mice
with an advantage during 
 
Listeria
 
 infection. This resistance
was accompanied by an amelioration of the lymphocyte
apoptotic process that took place during the early exponen-
tial growth of 
 
Listeria
 
 in tissues.
We and others have described an early transitory phase of
lymphocyte apoptosis in infective foci that peaks at 48 h af-
ter infection (7, 8). Experiments ex vivo indicated that liste-
riolysin O (LLO), a pore-forming molecule and major viru-
lence factor, caused lymphocyte apoptosis particularly in
cells that were replicating (9). Moreover, injection of pure
LLO subcutaneously led to lymphocyte apoptosis in the T
cell–rich zones of draining lymph nodes. Of note is that
during the in vivo infection the apoptotic lesions were ei-
ther not affected or were increased in mice in which IL-1,
IL-12, or IFN-
 
  
 
were either neutralized or not produced
(7). The lesions were unrelated to activation-induced cell
death, to Fas–Fas ligand interactions, or to the production of
reactive oxygen or nitrogen intermediates. In toto the evi-
dence points to the release of soluble LLO during the early
robust growth of 
 
Listeria
 
 as the mechanism leading to the
apoptotic death of lymphocytes in infective foci. In fact,
neutralization of LLO by injection of monoclonal antibody
to LLO controlled the infection as well as the intensity of
the apoptotic lesions (10). The data presented herein sug-
gests that type I IFN sensitizes lymphocytes to undergo
apoptosis during 
 
Listeria
 
 infection, and that this has a nega-
tive effect on bacterial handling in the mouse.
 
Materials and Methods
 
Mice and Listeria Infection.
 
Wild-type and IFN-
 
  
 
R
 
 
 
/
 
  
 
mice
on the 129Sv/Ev genetic background were provided by H.W.
Virgin IV (Washington University School of Medicine, St. Louis,
MO; reference 3). 
 
L. monocytogenes
 
 strain EGD was used as before
for intraperitoneal infection (7). Histological examination of he-
matoxylin and eosin– and TdT-mediated dUTP nick-end label-
ing (TUNEL)-stained sections was performed on the spleens
from infected mice (7). Cytometric bead array (CBA) analysis
was performed with the Mouse Inflammation Kit and used ac-
cording to the manufacturer’s instructions with 50 
 
 
 
L serum per
assay (BD Biosciences). CBA data was analyzed on a FACSCali-
bur™ with CELLQuest™ software and the CBA analysis soft-
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ware package (BD Biosciences). For flow cytometric staining,
portions of spleens from infected mice were disrupted to generate
single cell suspensions. Cells were then stained for CD69 and ei-
ther CD4 or CD8 using conventional techniques. All antibodies
were obtained from BD Biosciences.
 
Cell Cultures.
 
A CD4 T cell line reactive to ovalbumin was
generated from normal 129Sv/J mice (The Jackson Laboratory)
immunized with an ovalbumin emulsion in complete Freund’s
adjuvant using previously described techniques (9). The line was
passaged every 10–12 d by the addition of irradiated 129Sv/J
splenocytes (3,000 rads), 10 
 
 
 
M ovalbumin, and 50 U/ml IL-2.
The usual behavior was that of proliferation that slowly stopped
by about day 8. On day 10 after stimulation, the T cells were har-
vested and were not in cell cycle. Assays with the T cell line were
performed as described previously (9). Whole splenocytes were
isolated from 129Sv/Ev or IFN-
 
  
 
R
 
 
 
/
 
  
 
mice. Single cell sus-
pensions were made and cells were plated at a density of 5 
 
  
 
10
 
6
 
cells/ml in DMEM and 10% FCS, and treated with recombinant
mouse IFN-
 
 
 
A at 1, 10, or 100 U/ml (specific activity: 4.8 
 
 
 
10
 
7 
 
U/mg; PBL Biomedical Laboratories). Cells were incubated
for 24 h, and then the nonadherent cells were removed and puri-
fied. Both the T cell line and the splenocytes were purified over a
Histopaque 1119 gradient (Sigma-Aldrich). After Histopaque,
cells were resuspended in DMEM containing 1% FCS, and then
treated with 250 ng/ml of purified recombinant LLO (4.4 nM)
for 6 h. Cells were stained with annexin V-PE and 7-AAD (BD
Biosciences), and analyzed by flow cytometry. For assays involv-
ing splenocytes, cells were also stained with anti–CD3-APC (BD
Biosciences) to identify T cells.
 
Results and Discussion
 
Listeria Infection.
 
Infection of 129Sv/Ev mice with 
 
Lis-
teria
 
 showed the expected increase in the number of organ-
isms in the spleen and liver as a function of time (Fig. 1, A
and B). IFN-
 
  
 
R
 
 
 
/
 
  
 
mice had the same number of 
 
Listeria
 
as wild-type mice 24 h after infection. Therefore, there was
no difference between the two strains during the initial in-
nate resistance to infection, which was mediated by neu-
trophils and macrophages (1). However, at 48 h after infec-
tion, there was about a 20-fold increase in CFUs in both
the spleens and livers of wild-type versus IFN-
 
  
 
R
 
 
 
/
 
 
 
mice. By 96 h after infection, IFN-
 
  
 
R
 
 
 
/
 
  
 
mice had no
further 
 
Listeria
 
 growth and showed 
 
 
 
1,200-fold fewer
CFUs per organ (Fig. 1, A and B).
At 48 h after infection, the peak time at which lympho-
cyte apoptosis was evident, histological examination showed
a marked difference between both sets of mice (Fig. 2). The
difference in lymphocyte apoptosis was seen at three differ-
ent infectious doses (Table I). Wild-type mice showed in-
fective foci around the periarteriolar lymphoid sheath, char-
acterized by a paucity of lymphocytes and the presence of
Figure 1. Bacterial burden and cytokine profile of
129Sv/Ev and IFN-  R    mice infected with L. monocy-
togenes. Mice were infected with 2.5   104 Listeria intra-
peritoneally and at the indicated days after infection (P.I.).
CFUs were assessed in the spleen (A) and liver (B). Serum
CBA analysis was performed on the same mice to yield se-
rum concentrations of IL-6 (C), TNF-  (D), IFN-  (E),
and IL-12 (F). Bars represent the means   the SEM of at
least two independent experiments with a total number of
five to seven mice per group. 
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macrophages and neutrophils. Abundant TUNEL
 
  
 
round
nuclei were evident (Fig. 2 B). (Previous histochemical and
ultrastructural studies have shown these TUNEL
 
  
 
cells to
be lymphocytes [7]). At the highest infectious dose tested
(5 
 
  
 
10
 
4
 
), lesions extended into the periphery of the follicles
(Fig. 2 B). These lesions were identical to those previously
reported for several strains of mice (7). In contrast, IFN-
 
  
 
R
 
 
 
/
 
  
 
mice showed infective lesions with a considerably
reduced number of TUNEL
 
  
 
nuclei (Fig. 2 D and Table I).
Examination at 24 h after infection showed minor changes
in the periarteriolar lymphoid sheath and only occasional
TUNEL
 
  
 
cells in both strains of mice.
Analysis of cytokines in the serum of infected mice at
24 h after infection, a time when there was no difference in
 
Listeria
 
 load, showed an equal increase in both IL-6 (Fig. 1
C) and IFN-
 
  
 
(Fig. 1 E) in both strains. However, the con-
centration of IL-12 was markedly higher in the IFN-
 
  
 
R
 
 
 
/
 
 
 
mice (Fig. 1 F). The elevated level of IL-12 is consistent
with published data showing that type I IFN signaling re-
sulted in the down-regulation of IL-12 expression (11). The
cytokine profiles at 48 and 96 h shown in Fig. 1, C–F, likely
reflect the extent of infection in each strain (i.e., wild-type
mice showed continued 
 
Listeria
 
 growth, whereas IFN-
 
  
 
R
 
 
 
/
 
  
 
mice showed a limited 
 
Listeria
 
 burden).
During early 
 
Listeria
 
 infection, one sees a nonspecific
stage of T lymphocyte activation, made evident by the up-
regulation of CD69 cell surface expression (8). It has also
been shown that type I IFN signaling can induce CD69
expression on T cells (12). Moreover, in vivo 
 
Listeria
 
 infec-
tion induces type I IFN production (13, 14) and, in vitro,
 
Listeria
 
-infected macrophages produce type I IFN after
detecting the presence of an intracellular pathogen (15).
Therefore, we assayed 
 
Listeria
 
-infected wild-type and IFN-
 
  
 
R
 
 
 
/
 
  
 
mice for the percentage of CD4 and CD8 T cells
expressing CD69. Infected wild-type mice showed a three-
to sixfold increase in the number of CD69
 
  
 
T cells in their
spleens, whereas the increase in infected IFN-
 
  
 
R
 
 
 
/
 
 
 
mice was only two- to threefold. In uninfected 129Sv/Ev
mice, 4% of the CD8
 
  
 
T cells were CD69
 
 
 
. This number
increased to 13 and 25% at days 1 and 2 after infection, re-
spectively. In uninfected IFN-
 
  
 
R
 
 
 
/
 
  
 
mice, 4% of the
CD8
 
  
 
T cells were CD69
 
 
 
, which increased to 8 and 12%
at days 1 and 2, respectively. The picture was similar for
CD4
 
  
 
T cells, where in 129Sv/Ev mice, 10% of the CD4
 
 
 
cells were CD69
 
  
 
before infection, 18% were CD69
 
  
 
at
day 1, and 30% were CD69
 
  
 
at day 2 after infection. In
IFN-
 
  
 
R
 
 
 
/
 
  
 
mice, 8% of the CD4
 
  
 
cells were CD69
 
  
 
in
the uninfected mouse, with 10% CD69
 
  
 
at day 1 and 15%
CD69
 
  
 
at day 2 after infection. This difference in CD69
may reflect a higher level of activation of T lymphocytes in
wild-type mice, a step which could enhance their suscepti-
bility to 
 
Listeria
 
-induced apoptosis.
 
Response of T Cells to LLO in Culture.
 
We demonstrated
previously that treatment with sublytic doses of LLO in-
duced apoptosis in T cells (9). In that study, we observed a
difference in the extent of apoptosis between resting lym-
phocytes and those recently activated by exposure to anti-
gen. Because type I IFN is produced early during 
 
Listeria
 
 in-
fection (13–15), we hypothesized that the early burst of IFN
could enhance the susceptibility of lymphocytes to apoptosis.
We chose to monitor apoptosis in lymphocytes treated
with type I IFN by flow cytometry using annexin V that
binds to phosphatidylserine exposed on the outer leaflet of
the plasma membrane, and 7-AAD, which measures nuclear
permeability. This assay distinguishes apoptotic cells, which
stain with annexin V but not 7-AAD, from late apoptotic or
necrotic cells, which stain positive for both markers.
Figure 2. Histologic analysis of 129Sv/Ev and IFN-  R    mice in-
fected with L. monocytogenes. 129Sv/Ev (A and B) and IFN-  R /  (C
and D) mice were infected with 5   104 Listeria intraperitoneally and
spleens were removed and stained by either hematoxylin and eosin
(H&E) (A and C) or by TUNEL (B and D) 48 h later. Each panel shows
one white pulp profile stained by hematoxylin and eosin and the corre-
sponding profile stained by TUNEL. Pictures are representative profiles
from five mice per group. Bars, 50  m.
Table I. Spleens Examined 48 h after the Indicated Dose of Listeria
L. monocytogenes
dose Mice n
Pathology
(48 h)
Apoptosis
(48 h)
5   103 WT 4 30–50% - severe 3 
5   103 IFN-  R    5 10% - mild 1 
2.5   104 WT 4 50–100% - severe 4 
2.5   104 IFN-  R    5 10% - mild 1 
5   104 WT 5 75–100% - severe 4 
5   104 IFN-  R    6 20% - mild 1–2 
In pathology, the percentage refers to the number of white pulp profiles
showing the lesions. Severe means extensive depletion of lymphocytes,
mostly in the periarteriolar lymphoid sheath but extending to peripheral
areas of the pulp. Mild refers to a slight reduction localized to the
periarteriolar lymphoid sheath. TUNEL analysis shows varying numbers
of positive nuclei. Slides were scored blindly by one of us.Effect of Type I IFN on Listeria Infection and Apoptosis 538
We first tested CD4  T lymphocytes from ex vivo culture
10 d after antigen stimulation by incubating them in the
presence or absence of IFN- A for 24 h, and then exposing
them to 250 ng/ml LLO for 6 h. We selected this time point
on the basis of previous kinetic studies on cultured T cells
treated with LLO (9). In the absence of LLO, 8–10% of cells
underwent apoptosis (i.e., became annexin V /7-AAD ).
6 h of treatment with LLO increased this number to  22%,
in accordance with our previous study (Fig. 3, A, D, and J;
reference 9). The set of cells staining with both annexin V
and 7-AAD also increased upon LLO treatment. Our previ-
ous study demonstrated that LLO-treated cells shifted over
time from the single positive (annexin V /7-AAD ) to the
double positive (annexin V /7-AAD ), the latter of which
contains late apoptotic as well as necrotic cells (9).
Treatment with IFN- A alone did not significantly
increase the number of apoptotic cells. Annexin V /7-
AAD  cells constituted, on average, 8, 8, and 10% of the
cells after treatment with 1, 10, and 100 U/ml IFN- A, re-
spectively (Fig. 3 J). However, treatment with IFN- A
augmented the number of cells undergoing LLO-induced
apoptosis, in a dose-dependent manner. Cells treated with
1, 10, and 100 U/ml IFN- A and then exposed to 250 ng/
ml LLO had annexin V /7-AAD  populations of 29, 38,
and 43%, respectively (Fig. 3, G and J).
To extend our results to primary cells, we isolated sple-
nocytes, cultured them for 24 h in increasing doses of IFN-
 A, treated them with LLO, and assayed them for apopto-
sis by annexin V/7-AAD staining. As an average, 13% of
untreated CD3  cells were annexin V /7-AAD  (Fig. 3, B
and K). This number increased to 24% upon LLO treat-
ment (Fig. 3, E and K). The addition of type I IFN in-
creased the response of T cells to LLO-induced apoptosis
in a dose-dependent manner. At the highest IFN- A dose
tested (100 U/ml), 37% of cells CD3  became annexin
V /7-AAD  (Fig. 3, H and K). This increase, albeit mod-
est, was highly reproducible in three experiments. In con-
trast, type I IFN did not increase LLO-induced apoptosis in
splenocytes isolated from IFN-  R /  mice. The percent-
age increase in annexin V /7-AAD  cells taken from IFN-
  R /  spleen after treatment with LLO was the same in
the absence of IFN- A (Fig. 3, F and L) and at all doses of
IFN- A tested (Fig. 3, I and L).
(Spleen cells from wild-type mice cultured for 2, 4, and
6 h with LLO resulted in 26, 29, and 24% of annexin V /
7-AAD  cells, respectively. The addition of IFN- A in-
Figure 3. Annexin V/7-AAD
analysis of LLO-treated lympho-
cytes. A cultured, resting T cell line
(A, D, G, and J) and 129Sv/Ev sple-
nocytes (B, E, H, and K) or IFN-
  R /  splenocytes (C, F, I, and L)
were either untreated (A–C), treated
with 250 ng/ml LLO (D–F), or
treated with 250 ng/ml LLO after
24 h of treatment with 100 U/ml
IFN- A (G–I). Cells were stained
for annexin V/7-AAD. For the
spleen, data is gated on CD3  events
only. The flow cytometry plots
shown in A–I are representative of
two to three experiments. J–L show
the average result of two experi-
ments with the cell line and three
with the splenocytes, each per-
formed in duplicate or triplicate. J–L
show the percentage of annexin V /
7-AAD  cultured cells after the in-
dicated treatments. Although their
number is related with responsive-
ness to IFN- A, the double positive
cells taken from the spleen are not,
probably because they represent a
mixture of cells varying in their in
vitro susceptibility. J, T cell line; K,
wild-type spleen cells; L, IFN-
  R /   spleen cells. Asterisks in-
dicates statistical significance at a
p-value of  0.0001 (*) or  0.0041
(**) by unpaired t test.Carrero et al. Brief Definitive Report 539
creased the number of cells at the same time points to 35,
42, and 37%. Spleen cells from the IFN- R    mice cul-
tured for 2, 4, and 6 h with LLO resulted in 30, 32, and
30%, respectively. However, this number did not increase
after culture in IFN- A: 29, 31, and 30%. Both untreated
spleen cell populations were 16% annexin V /7-AAD 
cells after 6 h of culture. Thus, there were no major
changes in kinetics during the 2–6-h time period. Fig. 3
shows the 6 h results.)
Comments. Our experiments with IFN-  R /  mice
indicate a deleterious effect on early resistance to Listeria in-
fection by type I IFNs. Fehr et al. (16) reported that IFN-
  R /  mice were not impaired in their resistance to Lis-
teria infection. Moreover, their results suggested an increased
resistance to Listeria at day 5 after infection when compared
with wild-type controls. They hypothesized that this was a
function of type I and II IFN receptor competition for
components of signaling pathways. However, that study,
which focused on the role of transcription factors and nitric
oxide in resistance to Listeria, did not fully explain the in-
creased resistance of IFN-  R /  mice.
Our report expands on previous findings in the follow-
ing ways. In the absence of a response to type I IFNs (i.e.,
in the receptor null mice), the infective foci contained
fewer TUNEL  lymphocytes as well as fewer activated T
cells. Type I IFN unresponsive mice were also more resis-
tant to infection. We believe that early type I IFN produc-
tion during Listeria infection results in nonspecific activa-
tion of T cells. The provocative finding is that this early
activation also sensitizes these cells to the apoptogenic ac-
tions of LLO. Furthermore, macrophages treated with type
I IFN were shown to be susceptible to Listeria killing in
vitro (17). These results suggest that type I IFN could en-
hance the susceptibility to death of multiple leukocyte sub-
sets during Listeria infection.
The immunological consequences of cellular death dur-
ing  Listeria infection of the mouse must be further ex-
amined, but could involve the development of responses
that are inhibitory for bacterial clearance. Clearance of
apoptotic bodies by macrophages is generally thought to
down-regulate inflammation through macrophage release
of TGF- , prostaglandin E2, and platelet-activating factor
(18–20). Apoptotic lymphocytes themselves may also down-
regulate inflammation through the release of preformed
TGF-  upon apoptosis induction (21). We suggest an in-
verse relationship between death by apoptosis, in part en-
hanced by type I IFNs and the growth of Listeria. In the ab-
sence of type I IFN signaling, apoptosis is limited, and less
inhibition of phagocyte antimicrobial processes takes place.
In support of these hypotheses, we have observed that SCID
mice, lacking T and B lymphocytes, do not show apoptotic
lesions after Listeria infection, and are more resistant than
wild-type mice during the first 2–4 d after infection (22
and unpublished data).
The cellular source of type I IFN during Listeria infec-
tion and the Listeria component(s) inducing its production
remain unknown at this time. Candidate ligands would in-
clude Toll-like receptor (TLR)4 or TLR9 agonists such as
lipoteichoic acid or CpG DNA motifs, which have been
shown to induce type I IFN expression by dendritic cells
(23). Analysis of TLR4 / , TLR9 / , and MyD88 / 
mice or cells may yield insight into the generation of type I
IFN in response to Listeria infection. Macrophages recog-
nizing cytosolic Listeria also generate IFN-  (15), suggest-
ing this cell type as a source for the cytokine. Alternatively,
Listeria could generate proteins that promote expression of
type I IFN to enhance its virulence and dissemination.
A classical role ascribed to type I IFN signaling is the en-
hancement of cancer cell and virus-infected cell apoptosis.
One possible mechanism for type I IFN’s sensitization of T
cells to undergo apoptosis would be the accumulation of the
p53 tumor suppressor gene (24). After p53 expression, cellu-
lar stress caused by LLO disruption of the plasma membrane
might then lead to apoptosis induction. Further studies will
examine the role of type I IFNs in LLO-induced apoptosis.
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